AEON Biopharma Inc. (AEON)

NASDAQ: AEON · Real-Time Price · USD

0.44

0.01 (1.62%)

At close: May 01, 2025, 3:59 PM

0.45

3.99%

Pre-market: May 02, 2025, 06:58 AM EDT

AEON Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	42.01M	-52.56M	-55.64M	-32.91M	160.31M
Depreciation & Amortization	97K	68K	3K	n/a	1.26M
Stock-Based Compensation	6.25M	5.89M	5.22M	4.79M	5.25M
Other Working Capital	-1.82M	-345K	2.31M	933K	3.54M
Other Non-Cash Items	-69.35M	-3K	19.38M	17.21M	-196.96M
Deferred Income Tax	n/a	4.75M	1.18M	n/a	-14.64M
Change in Working Capital	706K	6.27M	1.42M	1.45M	50K
Operating Cash Flow	-20.29M	-35.58M	-28.43M	-9.46M	-44.73M
Capital Expenditures	n/a	-306K	-170K	n/a	-1.69M
Cash Acquisitions	n/a	n/a	n/a	-1.26M	-36.53M
Purchase of Investments	n/a	n/a	n/a	n/a	-89.07M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	10M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	-306K	-170K	-1.26M	-117.29M
Debt Repayment	15M	40.51M	15M	25.11M	9.68M
Common Stock Repurchased	n/a	n/a	n/a	n/a	-64K
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	-1.44M	-541K	-14.2M
Financial Cash Flow	15.15M	40.51M	13.56M	24.57M	73.21M
Net Cash Flow	-5.14M	4.62M	-15.04M	13.84M	-88.8M
Free Cash Flow	-20.29M	-35.89M	-28.6M	-9.46M	-46.42M